Capabilities

Research


 

Research

Our sector specialties include: Consumer; Healthcare; Power & Energy Transition; and Technology/Media. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.

Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:

  • The Guggenheim 360° series spotlights our analysts' most differentiated work—research that reflects a deep understanding of our covered industries, primary studies using proprietary methods, access to subject matter experts, thought-provoking conclusions, and actionable portfolio ideas;
  • The Guggenheim Data Insights series harnesses alternative data sources to identify changes in fundamental trends in the industries and businesses we cover. With an emphasis on complex and unstructured data sets, our data science team delivers fundamental observations for our analysts to incorporate into their investment opinions.

Meet the Teams

Consumer

The Consumer team covers hardline and softline retail, automotive, restaurants, and e-commerce.

View the Team

Power & Energy Transition

The Power & Energy Transition team covers energy & industrial technology, power, and utilities.

View the Team

Healthcare

The Healthcare team covers biotechnology, biopharmaceuticals, healthcare IT, and healthcare services.

View the Team

Technology & Media

The Technology & Media team covers software, media, and entertainment.

View the Team

For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.

Already Registered? View the content library on the research portal (login required).

360° and Data Insights


Video Highlights


I&I Spotlight Series – Treg-based Therapies

I&I Spotlight Series – Treg-based Therapies

Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.

Watch Video

Tech-Enabled Care Industry Overview

Tech-Enabled Care Industry Overview

Head of Equity Research Craig Peckham, Healthcare IT & Services Research Analysts Sandy Draper and Jack Wallace discuss their insights on the tech-enabled care industry.

Watch Video

Highlights From the Second Guggenheim Targeted Protein Day

Highlights From the Second Guggenheim Targeted Protein Day

Senior Managing Director Michael Schmidt discusses the key topics from the event.

Watch Video

Conferences


DateSectorConference Name
6/20-6/23HealthcareBiopharma's Next Decade Bus Tour: Views from the Top on Global Strategy and Innovation
6/22HealthcareBiopharma's Next Decade Bus Tour Reception

Social Media Showcases


Michael Morris Discusses Recent Developments in Entertainment Sector

Linkedin: CNBC

Michael Morris Discusses Recent Developments in Entertainment Sector

Entertainment & Digital Media Equity Research Analyst Michael Morris joins CNBC's "Squawk on the Street" to discuss recent developments and long-term outlook in the sector.

Read More

Guggenheim Thanks Attendees and Participants of Radiopharmaceuticals Day

LinkedIn: Guggenheim Securities

Guggenheim Thanks Attendees and Participants of Radiopharmaceuticals Day

Guggenheim would like to thank the participants and attendees of the Guggenheim Healthcare Talks Radiopharmaceuticals Day.

Read More

Shahriar Pourreza Talks With WSJ About Investment Opportunities In Hydrogen

LinkedIn: WSJ

Shahriar Pourreza Talks With WSJ About Investment Opportunities In Hydrogen

Senior Managing Director and Power & Utilities Equity Research Analyst Shar Pourreza, CFA spoke with Katherine Blunt at The Wall Street Journal about investment opportunities in hydrogen.

Read More

Ron Jewsikow Discusses Earnings on Yahoo Finance

LinkedIn: Yahoo Finance

Ron Jewsikow Discusses Earnings on Yahoo Finance

Automotive Equity Research Analyst Ron Jewsikow joins Yahoo Finance to discuss recent earnings reports.

Read More

Gregory Francfort Talks Restaurants Outlook on Yahoo Finance

LinkedIn: Yahoo Finance

Gregory Francfort Talks Restaurants Outlook on Yahoo Finance

Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo Finance to discuss his outlook for restaurants.

Read More

Genomic Medicines and Rare Disease Days

LinkedIn: Thank You

Genomic Medicines and Rare Disease Days

Guggenheim would like to thank the participants and attendees of the Guggenheim Healthcare Talks Genomic Medicines and Rare Disease Days.

Read More

Vamil Divan Launches Healthcare Stock Coverage

LinkedIn: Healthcare Research

Vamil Divan Launches Healthcare Stock Coverage

Vamil Divan, MD, MBA, Healthcare Equity Research Analyst covering the Global Biopharmaceutical and Biotechnology sectors, expanded Guggenheim Securities’ Healthcare Research footprint in late February by launching coverage on nine healthcare stocks.

Read More

Software Equity Research Analyst John DiFucci Discusses Takeaways From Salesforce's Earnings Call

LinkedIn: Yahoo Finance

Software Equity Research Analyst John DiFucci Discusses Takeaways From Salesforce's Earnings Call

Software Equity Research Analyst John DiFucci joins Yahoo Finance to discuss his key takeaways from Salesforce's fourth-quarter earnings call.

Read More

Software Equity Research Analyst John DiFucci Joins CNBC's Squawk on the Street

LinkedIn: CNBC Squawk on the Street

Software Equity Research Analyst John DiFucci Joins CNBC's Squawk on the Street

Software Equity Research Analyst John DiFucci joins CNBC’s "Squawk on the Street" to discuss his thoughts and outlook on cloud stocks.

Read More

Gregory Francfort Discusses Subscription Services in the Restaurants Sector

LinkedIn: Yahoo! Finance

Gregory Francfort Discusses Subscription Services in the Restaurants Sector

Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo! Finance to discuss his views on subscription services in the restaurant sector.

Watch Video

Why Olive Garden parent Darden Restaurants is still ‘best in class’: Analyst

LinkedIn: Yahoo! Finance

Why Olive Garden parent Darden Restaurants is still ‘best in class’: Analyst

Restaurants Equity Research Analyst Gregory Francfort, CFA joins Yahoo! Finance to discuss his views and outlook on the sector.

Watch Video

Software Equity Research Analyst John DiFucci Joins CNBC’s Squawk Box

LinkedIn: CNBC Squawk Box

Software Equity Research Analyst John DiFucci Joins CNBC’s Squawk Box

Software Equity Research Analyst John DiFucci joins CNBC’s "Squawk Box" to discuss his views on the sector as well as the impact of artificial intelligence on the industry.

Read More

Guggenheim Software Analyst John DiFucci Joins CNBC’s TechCheck

LinkedIn: CNBC TechCheck

Guggenheim Software Analyst John DiFucci Joins CNBC’s TechCheck

Guggenheim software analyst John DiFucci joins CNBC’s ‘TechCheck’ to discuss his software sector outlook.

Read More

Shar Pourreza Discusses Utility Industry With New York Times

LinkedIn: New York Times

Shar Pourreza Discusses Utility Industry With New York Times

Senior Managing Director Shar Pourreza, CFA spoke with The New York Times' reporter Eric Lipton on the utility industry’s outlook with the passage of the climate and economic legislation Inflation Reduction Act.

Read More

Guggenheim’s Seamus Fernandez Offers His Bullish Case for Merck

LinkedIn: CNBC Closing Bell: Overtime

Guggenheim’s Seamus Fernandez Offers His Bullish Case for Merck

Biopharmaceutical Analyst Seamus Fernandez provides insight on CNBC Closing Bell: Overtime into his recent report on MRK.

Read More

Therapeutics Conference

LinkedIn: Therapeutics Conference

Therapeutics Conference

Guggenheim Securities would like to thank the participants and attendees of this week’s Therapeutics Conference.

Read More

New Duke Energy CFO Steps Into Role as Utility Considers Sale of Renewables Business

LinkedIn: Equity Research Analysts

New Duke Energy CFO Steps Into Role as Utility Considers Sale of Renewables Business

Equity Research Analyst Shar Pourreza, CFA comments on Duke Energy’s outlook and plans to manage its capital structure.

Read More

I&I Spotlight Series - Treg-based Therapies

LinkedIn: I&I Spotlight Series

I&I Spotlight Series - Treg-based Therapies

Senior Healthcare Sales Specialist Whitney Wolfe interviews Biotechnology Research Analyst Yatin Suneja, covering the biotechnology sector, on the rapid innovation of Tregs for the treatment of autoimmune diseases and diseases of the nervous system.

Read More